On June 24, 2025, CalciMedica, Inc. held its Annual Meeting where stockholders approved an increase of 600,000 shares in the company’s Amended 2023 Equity Incentive Plan. Additionally, they elected three Class II directors and ratified Baker Tilly US, LLP as the accounting firm for 2025.